Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
BioXcel Therapeutics (BX20.F) Q1 2025 Earnings
BX20.F
27
Mar
Confirmed
Q4 2024
Q1 2025
-7.68
-6.22
-4.76
-3.31
Details
Expected EPS
-5.59583991712
Actual EPS
-3.3052487999999998
Surprise EPS
2.29
Surprise Percent
+40.93%
Description
BioXcel Therapeutics (BX20.F) has reported earnings of -3.3052487999999998 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login